It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

medicine

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
A Chilean tree holds hope for new vaccines — if supplies last

World / Science & Health | FOCUS Oct 7, 2021

A Chilean tree holds hope for new vaccines — if supplies last

by Aislinn Laing and Allison Martell

Quillay trees, technically known as Quillaja saponaria, are rare evergreens native to Chile that have long been used by the indigenous Mapuche people to make soap and medicine.

In major breakthrough, WHO backs malaria vaccine rollout for Africa's children

World / Science & Health Oct 7, 2021

In major breakthrough, WHO backs malaria vaccine rollout for Africa's children

The WHO says 94% of malaria cases and deaths occur in Africa, a continent of 1.3 billion people.

Japan in talks to procure Merck oral drug for mild COVID-19 symptoms

National Oct 4, 2021

Japan in talks to procure Merck oral drug for mild COVID-19 symptoms

Molnupiravir was seen to halve the likelihood of hospitalization or death, according to an interim analysis of clinical trials across areas including Japan, Europe and the U.S.

How Japan’s new PM can take a lead in improving global health

Commentary / Japan Oct 3, 2021

How Japan’s new PM can take a lead in improving global health

by Kazuyo Kato

Prime Minister Suga's successor has a chance at becoming a global leader by helping end COVID-19 elsewhere in the world — a move that could also see Japan advance its foreign policy goals.

Japan urges prefectures to beef up medical systems ahead of winter virus wave

National Oct 2, 2021

Japan urges prefectures to beef up medical systems ahead of winter virus wave

by Osamu Tsukimori

The health ministry has called for expanding the number of available beds nationwide on the assumption that the next wave of the virus could be at least as bad as this summer's fifth wave.

Japan governors demand bolstered medical system as eased COVID-19 curbs stoke concern

National Oct 2, 2021

Japan governors demand bolstered medical system as eased COVID-19 curbs stoke concern

The National Governors' Association want sufficient hospital beds, tests and treatments for the coronavirus to be ensured in a draft proposal for the next government.

Nobel Prize in medicine for COVID-19 vaccine? It may be too soon.

World | FOCUS Oct 2, 2021

Nobel Prize in medicine for COVID-19 vaccine? It may be too soon.

Among those seen by other scientists as potential winners are Hungarian-born Katalin Kariko and American Drew Weissman for their work on what are known as messenger ribonucleic acid (mRNA) vaccines.

Merck pill seen as 'huge advance,' raises hope of preventing COVID-19 deaths

World / Science & Health Oct 2, 2021

Merck pill seen as 'huge advance,' raises hope of preventing COVID-19 deaths

An experimental antiviral pill developed by Merck & Co. could halve the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19.

Drug that stops ALS progression found using iPS cells from patients

National / Science & Health Oct 1, 2021

Drug that stops ALS progression found using iPS cells from patients

The team reproduced the disease by culturing iPS cells derived from the skin of patients into motor neurons.

Singapore's lauded COVID-19 response overlooked a major factor: fear

Commentary / World Sep 30, 2021

Singapore's lauded COVID-19 response overlooked a major factor: fear

by Rachel Rosenthal

Singapore's case count is low by global standards, but a recent spike is staggering for a country that had all but eliminated COVID-19 before the delta variant emerged.

Liars may get COVID-19 boosters before those in need

Commentary / World Sep 29, 2021

Liars may get COVID-19 boosters before those in need

by Max Nisen

Who will get the booster shots? Sadly, the answer is too many of the wrong people and too few of the right ones, adding more messiness to the rollout process.

Japan approves second drug for mildly ill COVID-19 patients

National / Science & Health Sep 27, 2021

Japan approves second drug for mildly ill COVID-19 patients

by Osamu Tsukimori

Sotrovimab was given the green light three weeks after GlaxoSmithKline’s Japan unit submitted its application for the antibody treatment to the health ministry.

« 1 … 24 25 26 … 46 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times